M&A Deal Summary |
|
|---|---|
| Date | 2020-04-16 |
| Target | Gaido Health |
| Sector | Information Technology |
| Buyer(s) | Biofourmis |
| Sellers(s) | Takeda Pharmaceuticals U.S.A. |
| Deal Type | Divestiture |
SEARCH BY
Biofourmis discovers, develops and delivers clinically validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, technology to demonstrate the value of and potentially complement pharmacotherapy, and cost-effective solutions for payers. Biofourmis was founded in 2015 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-18 |
Biovotion AG
Zurich, Switzerland Biovotion AG is a developer of a cutting-edge clinical-grade wearable biosensor platform. Biovotion was founded in 2011 and is based in Zurich, Switzerland. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Medical Products |
As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 15 pharmaceutical companies in the United States.Striving toward better health for people worldwide through leading innovation in medicine
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-17 |
URL Pharma
Philadelphia, Pennsylvania, United States URL Pharma, Inc. is a manufacturer of branded and generic medicines. Its core products include Qualaquin, Colcrys, Fibricor, and Bactrim. |
Sell | - |
